Home  >  Products  >  CD276 (CD276 molecule ) Blocking Peptide (the C terminal of CD276)(100ug)
CD276 (CD276 molecule ) Blocking Peptide (the C terminal of CD276)(100ug)

CD276 (CD276 molecule ) Blocking Peptide (the C terminal of CD276)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CD276 Antibody (ARP63929_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63929
Size: 100ug
Weight: 34kDa
Gene: 80381
Format: Lyophilized powder
Target: The protein encoded by this gene belongs to the immunoglobulin superfamily, and thought to participate in the regulation of T-cell-mediated immune response. Studies show that while the transcript of this gene is ubiquitously expressed in normal tissues and solid tumors, the protein is preferentially expressed only in tumor tissues. Additionally, it was observed that the 3' UTR of this transcript contains a target site for miR29 microRNA, and there is an inverse correlation between the expression of this protein and miR29 levels, suggesting regulation of expression of this gene product by miR29. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Alternative names: B7-H3; B7H3